KPC-2 producing Klebsiella pneumoniae and Escherichia coli co-infection in a catheter-related infection

Clinical Microbiology and Infection

Volumn 17, Issue 3, 2011, Pages 380-382

  Leao R S ^a   Carvalho Assef, A P D A ^b   Correal, J C D ^c   Silva, R V ^c   Goldemberg, D C ^d   Asensi, M D ^b   Marques, E A ^a,c  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antibiotic resistance; Carbapenemase; Escherichia coli; Klebsiella pneumoniae; KPC 2

Indexed keywords

AMIKACIN; AZTREONAM; BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEFEPIME; CEPHALOSPORIN; CREATININE; ERTAPENEM; IMIPENEM; KLEBSIELLA PNEUMONIAE CARBAPENEMASE TYPE BETA LACTAMASE; MEROPENEM; SULFAMETHOXAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BLOOD CULTURE; BLOODSTREAM INFECTION; BRAZIL; CASE REPORT; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMMUNITY ACQUIRED PNEUMONIA; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; FEVER; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYPERTENSION; INFECTION CONTROL; KIDNEY FAILURE; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LEUKOCYTOSIS; LUNG FUNCTION; MINIMUM INHIBITORY CONCENTRATION; MIXED INFECTION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 79751469573     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03268.x     Document Type: Article

References (21)

1. Yigit H, Queenam AM, Anderson GJ et al. Novel carbapenem-hidrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45: 1151-1161.
2. Cai J, Zhou CHW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008; 52: 2014-2018.
3. Leavitt A, Chmelnitsky I, Ofek I, Carmeli Y, Navon-Venezia S. Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resitance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. J Antimicrob Chemother 2010; 65: 243-248.
4. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009; 53: 333-334.
5. Pavez M, Mamizuka EM, Lincopan N. Early dissemination of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother 2009; 53: 3180.
6. Peirano G, Seki LM, Passos VLV, Pinto MCFG, Guerra LR, Asensi MD. Carbapenem-hydolysing β-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil. J Antimicrob Chemother 2009; 63: 265-268.
7. Zavascki AP, Zoccoli CM, Machado AB et al. KPC-2-producing Klebsiella pneumoniae in Brazil: a widespread threat in waiting? Int J Infect Dis 2010; 14: E539-E540.
8. Petrella S, Ziental Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother 2008; 52: 3725-3736.
9. Nordmann P, Poirel L. Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 2002; 8: 321-331.
10. Bennet JW, Herrera ML, Lewis JS, Wickes BW, Jorgensen JH. KPC-2 producing Enterobacter cloace and Pseudomonas putida co-infection in a liver transplant recipient. Antimicrob Agents Chemother 2009; 53: 292-294.
11. Anderson KF, Lonsway DR, Rascheed JK et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007; 45: 2723-2725.
12. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition off the beta-lactamase blaKPC gene. Antimicrob Agents Chemother 2008; 52: 1257-1263.
13. Pournaras S, Protonotariou E, Voulgari E et al. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64: 348-352.
14. Woodford N, Tierno PM, Young K Jr et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in New York Medical Center. Antimicrob Agents Chemother 2004; 48: 4793-4799.
15. Maltezou HC, Giakkoupi P, Maragos A et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 2009; 58: 213-219.
16. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing 19th informational supplement. Document M100-S19. Wayne, PA: CLSI, 2009.
17. Otto TD, Vasconcellos EA, Gomes LHF et al. ChromaPipe: a pipeline for analysis, quality control and management for a DNA sequencing facility. Genet Mol Res 2008; 7: 861-871.
18. Marschall J, Tibbetts RJ, Dunne WM Jr, Frye JG, Fraser VJ, Warren DK. Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility. J Clin Microbiol 2009; 47: 239-241.
19. Tenover FC, Kalsi RK, Williams PP et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006; 12: 1209-1213.
20. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC, SENTRY Particicpants Group (Latin America). SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 10997 through 2001. Braz J Infect Dis 2004; 8: 25-79.
21. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.